935455-28-0 ((S)-3-氨基四氢噻吩-1,1-二氧化物盐酸盐,(S)-3-Aminotetrahydrothiophene 1,1-dioxide hydrochloride)

CAS号:
935455-28-0
中文名称:
(S)-3-氨基四氢噻吩-1,1-二氧化物盐酸盐
英文名称:
(S)-3-Aminotetrahydrothiophene 1,1-dioxide hydrochloride
分子式:
C4H10ClNO2S
分子量:
171.6456990242

(S)-3-氨基四氢噻吩-1,1-二氧化物盐酸盐(935455-28-0)名称与标识符

名称

中文别名:
(3S)-3-thiophenamine,1,1-二氧化物,四氢,盐酸(1:1);(S)-3-氨基四氢噻吩1,1-二氧化物盐酸盐;2,4,5,6-四氢吡咯并[3,4-C]吡唑;
英文别名:
(S)-3-Aminotetrahydrothiophene 1,1-dioxide hydrochloride;(S)-3-aminotetrahydrothiophene 1,1-dioxide (hydrochloride);MGZQMSFXPSKBDY-WCCKRBBISA-N;(3S)-3-amino-1lambda6-thiolane-1,1-dione hydrochloride;(S)-3-Amino-tetrahydrothiophene 1,1-dioxide hydrochloride;(R)-Tetrahydrothiophen-3-amine 1,1-dioxide hydrochloride;(S)-(-)-tetrahydrothiophene-3-amine-1,1-dioxide hydrochloride;(3S)-3-ThiophenaMine tetrahydro-, 1,1-dioxide hydrochloride (1:1);C12856;(S)-3-AMINOTETRAHYDROTHIOPHENE 1,1-DIOXIDE HCL;(3S)-3-ThiophenaMine, tetrahydro-, 1,1-dioxide, hydrochloride (1;EN300-7614021;AKOS026675629;PS-8682;SCHEMBL1901330;(3S)-1,1-dioxothiolan-3-amine;hydrochloride;935455-28-0;CS-B0940;(S)-3-Aminotetrahydrothiophene1,1-dioxidehydrochloride;HY-20629;MFCD28952871;(3S)-3-amino-1??-thiolane-1,1-dione hydrochloride;

标识符

MDL:
MFCD28952871
InChIKey:
MGZQMSFXPSKBDY-WCCKRBBISA-N
Inchi:
1S/C4H9NO2S.ClH/c5-4-1-2-8(6,7)3-4;/h4H,1-3,5H2;1H/t4-;/m0./s1
SMILES:
O=S1(CC[C@H](N)C1)=O.Cl

(S)-3-氨基四氢噻吩-1,1-二氧化物盐酸盐(935455-28-0)物化性质

计算特性

  • 精确分子量 : 171.0120774g/mol
  • 氢键供体数量 : 2
  • 氢键受体数量 : 3
  • 可旋转化学键数量 : 0
  • 同位素质量 : 171.0120774g/mol
  • 重原子数量 : 9
  • 复杂度 : 167
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 1
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 2
  • 拓扑分子极性表面积 : 68.5

(S)-3-氨基四氢噻吩-1,1-二氧化物盐酸盐(935455-28-0)推荐厂家 更多厂家(9)

(S)-3-氨基四氢噻吩-1,1-二氧化物盐酸盐(935455-28-0)合成路线

合成路线:1 步
反应条件:
参考文献:
Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of phenyl and benzodioxinyl substituted indazoles for treatment of glucocorticoid receptor mediated diseases.
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Isoxazolyl-substituted benzimidazoles as p300 and/or CBP modulators and their preparation
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of indazole derivatives for use as diacylglyceride O-acyltransferase 2 inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of novel pyrrolo[2,3-d]pyrimidine compounds as GPR119 receptor agonists
, Japan, , ,
合成路线:1 步
反应条件:
参考文献:
Pharmaceutical compositions containing pyrazolo[1,5-a]pyrimidine compounds having CB1 receptor antagonistic effects
, Japan, , ,
合成路线:1 步
反应条件:
参考文献:
A pyrazolo[1,5-a]pyrimidine compound as CB1 antagonists and their preparation, pharmaceutical compositions and use in the treatment of diseases
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists and their preparation, pharmaceutical compositions and use in the treatment of diseases
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Preparation of trisubstituted pyrimidine compounds and their use as phosphodiesterase 10 (PDE10) inhibitors
, Japan, , ,
合成路线:1 步
参考文献:
Preparation of trisubstituted pyrimidines as phosphodiesterase PDE10 inhibitors
, World Intellectual Property Organization, , ,